Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study looked at the effect of vitamin D levels on the complications of type 2 diabetes and the fat profile of patients with diabetes.Participants in this study were divided into two groups. One group included participants with vitamin D deficiency and the other group did not.The first group receives 50,000 units of oral vitamin D 3 daily for up to 8 days.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with vitamin D deficiency | Experimental | This group receives 50,000 units of vitamin D3 daily for up to 8 days until the serum level of vitamin D reaches above 30 ng/ml. |
|
| Patients without vitamin D deficiency | Active Comparator | Participants in this group receive only their usual treatments |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vitamin D3 | Drug | For up to 8 days, 50,000 units of vitamin D3 are given daily to patients in the first group so that the serum level of vitamin D reaches above 30 g / ml. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Vitamin D serum levels | Vitamin D serum levels measured by blood tests | up to 1 year |
| Triglyceride | Level of blood triglycerides measured by a blood test | up to 1 year |
| Blood cholesterol levels | Blood cholesterol levels measured by a blood test | up to 1 year |
| HDL | Blood HDL levels measured by a blood test | up to 1 year |
| LDL | Blood LDL levels measured by a blood test | up to 1 year |
| Fasting blood glucose | Fasting blood glucose levels measured by a blood test | up to 1 year |
| Neuropathy | Neuropathy based on United Kingdom Screening TEST | up to 1 year |
| Nephropathy | Nephropathy based on albumin excretion evaluation | up to 1 year |
| Retinopathy | Retinopathy based on an ophthalmologist's examination |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mohammad Sadegh Bagheri Baghdasht | Tehran | 0 | Iran |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D002762 | Cholecalciferol |
| ID | Term |
|---|---|
| D002782 | Cholestenes |
| D002776 | Cholestanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Routine treatment | Drug | In this group, patients receive their usual medications and treatments |
|
| up to 1 year |
| blood pressure | Systolic and diastolic blood pressure measured by Sphygmomanometer | up to 1 year |
| HBA1C | Blood sugar levels measured in the last three months measured by blood test | up to 1 year |
| D004700 | Endocrine System Diseases |
| D011083 |
| Polycyclic Compounds |
| D013261 | Sterols |
| D014807 | Vitamin D |
| D012632 | Secosteroids |
| D008563 | Membrane Lipids |
| D008055 | Lipids |